ResourceClinical Diagnostics
Evaluation of the accuracy of LumiraDx INR Test in patients taking Phenprocoumon as VKA Therapy
13 Oct 2022This application note discusses the results of a study conducted in a German clinic to compare International Normalised Ratio (INR) results obtained with patients taking Phenprocoumon as a vitamin k antagonist (VKA) therapy, determined using the LumiraDx INR Test and fingerstick blood samples.
Related Products
Request Quote for All Products
INR Test
LumiraDxThe LumiraDx INR Test measures prothrombin time reported as International Normalized Ratio (INR) from a single, direct fingerstick blood sample – all in less than 90 seconds*. The Test is used for monitoring patients on oral anticoagulation therapy with Vitamin-K Antagonist (VKA) drugs. Used with the LumiraDx Instrument, the Test delivers rapid results at the point of care.